Source:http://linkedlifedata.com/resource/pubmed/id/10603935
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2000-1-7
|
pubmed:abstractText |
Congestive heart failure is a significant clinical problem and leads to abnormalities in Ca2+ transients and to decreases in the level of the Ca2+ ATPase of the sarcoplasmic reticulum according to reports to some investigators. The Ca2+ ATPase of the sarcoplasmic reticulum (SERCA2) contributes in an important manner to diastolic Ca2+ lowering and relaxation of the heart. To determine the contractile alterations resulting from increased SERCA2 expression, we generated transgenic mice overexpressing a rat SERCA2 transgene. In these mice, SERCA2 mRNA was increased 2.6-fold, the relative synthesis rate of SERCA2 protein 1.8-fold, and SERCA2 protein levels 1.2-fold. Functional analysis of Ca2+ handling and contractile parameters in isolated cardiac myocytes indicated that the intracellular Ca2+ decline and myocyte relengthening were each accelerated by 22-23%. In addition, studies in isolated papillary muscles showed that the time to half-maximal post-rest potentiation was significantly shorter, hinting at an increased Ca2+ loading of the sarcoplasmic reticulum. Furthermore, in vivo cardiac functional studies demonstrated a significant accelerated contraction and relaxation in SERCA2 transgenic mice. We also cloned a SERCA2 transgene and mutants of the phospholamban gene into E1 deleted replication-deficient human adenovirus 5 viral vectors and infected cardiac myocytes. In the cardiac myocytes, endogenous SERCA2 levels were decreased by PMA treatment. Infection of such myocytes with a SERCA2 expressing adenovirus could reconstitute the Ca2+ transient, and augmented oxalate facilitated SERCA2 Ca2+ uptake. In addition, phospholamban mutants with changes of basic to acidic amino acids in the cytoplasmic domain increased SERCA2 activity by 30-35%. These findings, therefore, suggest that increased SERCA2 activity can be achieved by increasing SERCA2 levels or by expressing phospholamban mutants. Increased SERCA2 activity can lead to significant enhancements of Ca2+ transients and myocardial contractility.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0077-8923
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
853
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-8
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10603935-Animals,
pubmed-meshheading:10603935-Calcium,
pubmed-meshheading:10603935-Calcium-Transporting ATPases,
pubmed-meshheading:10603935-Diastole,
pubmed-meshheading:10603935-Heart,
pubmed-meshheading:10603935-Humans,
pubmed-meshheading:10603935-Mice,
pubmed-meshheading:10603935-Mice, Transgenic,
pubmed-meshheading:10603935-Myocardial Contraction,
pubmed-meshheading:10603935-Rats,
pubmed-meshheading:10603935-Sarcoplasmic Reticulum
|
pubmed:year |
1998
|
pubmed:articleTitle |
Influences of increased expression of the Ca2+ ATPase of the sarcoplasmic reticulum by a transgenic approach on cardiac contractility.
|
pubmed:affiliation |
Department of Medicine, University of California, San Diego 92093-0618, USA.
|
pubmed:publicationType |
Journal Article
|